Wellington Management Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.5M Sell
568,347
-170,282
-23% -$11.1M 0.01% 706
2026
Q1
$35.1M Sell
738,629
-74,493
-9% -$3.34M 0.01% 835
2025
Q4
$25.8M Buy
813,122
+513,309
+171% +$16M ﹤0.01% 946
2025
Q3
$8.44M Sell
299,813
-277,250
-48% -$8.4M ﹤0.01% 1310
2025
Q2
$21.2M Sell
577,063
-183,888
-24% -$6.35M ﹤0.01% 941
2025
Q1
$29.9M Sell
760,951
-25,361
-3% -$1.14M 0.01% 834
2024
Q4
$36.5M Sell
786,312
-11,425
-1% -$516K 0.01% 798
2024
Q3
$36M Buy
797,737
+521,272
+189% +$24.8M 0.01% 794
2024
Q2
$13.6M Buy
276,465
+248,411
+885% +$10.1M ﹤0.01% 1066
2024
Q1
$963K Buy
28,054
+1,572
+6% +$56.7K ﹤0.01% 1697
2023
Q4
$976K Buy
+26,482
New +$612K ﹤0.01% 1630
2023
Q3
– Sell
-32,287
Closed -$661K – 1893
2023
Q2
$661K Buy
+32,287
New +$484K ﹤0.01% 1660
2020
Q4
– Sell
-949,101
Closed -$72.1M – 2013
2020
Q3
$72.1M Sell
949,101
-304,039
-24% -$18.9M 0.01% 594
2020
Q2
$56.8M Sell
1,253,140
-75,092
-6% -$2.69M 0.01% 664
2020
Q1
$40.6M Buy
+1,328,232
New +$35.7M 0.01% 693

Other funds holding TWST

Wellington Management Group's TWST Position: Q2 2026 in Review

Wellington Management Group reduced its Twist Bioscience (TWST) stake by 23% in Q2 2026, selling an estimated $11.1M and leaving 568,347 shares worth $58.5M. The position accounts for 0.01% of the portfolio, ranked #706.

Wellington Management Group first reported a position in TWST in Q1 2020 and has held it in 15 quarters since. The position peaked at $72.1M in Q3 2020. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Wellington Management Group held 568,347 shares of Twist Bioscience worth $58.5M as of Q2 2026.
  • Wellington Management Group sold 170,282 Twist Bioscience shares in Q2 2026, an estimated $11.1M.
  • Twist Bioscience made up 0.01% of Wellington Management Group's portfolio in Q2 2026, its #706 holding.
  • Wellington Management Group first reported a position in Twist Bioscience in Q1 2020 and has held it in 15 quarters since.
  • Wellington Management Group's Twist Bioscience position peaked at $72.1M in Q3 2020.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.